May 6 (Reuters) - Hedge fund Shah Capital said on Monday
that it intends to vote against election of three directors on
the board of COVID-19 vaccine maker Novavax ( NVAX ).
Shah Capital said it currently owns about 7.5% of Novavax's ( NVAX )
outstanding shares.